- Inspire Medical Systems press release ( NYSE: INSP ): Q2 GAAP EPS of -$0.53 beats by $0.07 .
- Revenue of $91.4M (+72.6% Y/Y) beats by $13.34M .
- Given the positive trends during the second quarter, Inspire is increasing its full year 2022 revenue guidance to between $354 million to $362 million, which would represent growth of 52% to 55% over full year 2021 revenue of $233.4 million. This compares to the prior revenue guidance of $336 million to $344 million.
- The Company is adjusting its full year 2022 gross margin guidance to 83% to 85% from the previous guidance of 85% to 86%.
For further details see:
Inspire Medical Systems GAAP EPS of -$0.53 beats by $0.07, revenue of $91.4M beats by $13.34M